MASS Logo

908 Devices Inc. (MASS) 

NASDAQ
Market Cap
$95.24M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
171 of 774
Rank in Industry
23 of 99

Largest Insider Buys in Sector

MASS Stock Price History Chart

MASS Stock Performance

About 908 Devices Inc.

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the …

Insider Activity of 908 Devices Inc.

Over the last 12 months, insiders at 908 Devices Inc. have bought $293,400 and sold $541,661 worth of 908 Devices Inc. stock.

On average, over the past 5 years, insiders at 908 Devices Inc. have bought $10.34M and sold $10.6M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Knopp Kevin J. (President and CEO) — $293,400.

The last purchase of 10,000 shares for transaction amount of $64,200 was made by Knopp Kevin J. (President and CEO) on 2024‑05‑13.

List of Insider Buy and Sell Transactions, 908 Devices Inc.

2024-05-13PurchasePresident and CEO
10,000
0.0284%
$6.42$64,200-37.61%
2024-05-10PurchasePresident and CEO
10,000
0.0294%
$5.77$57,700-27.89%
2024-05-09PurchasePresident and CEO
10,000
0.0294%
$5.83$58,300-27.78%
2024-05-08PurchasePresident and CEO
10,000
0.0291%
$5.72$57,200-26.01%
2024-05-07PurchasePresident and CEO
10,000
0.0302%
$5.60$56,000-26.05%
2024-02-02SaleChief Financial Officer
9,711
0.029%
$7.09$68,873-20.53%
2024-02-01SaleChief Product Officer
3,957
0.0117%
$7.01$27,730-21.08%
2024-02-01SalePresident and CEO
9,071
0.0267%
$7.00$63,461-21.08%
2024-02-01SaleChief Financial Officer
5,698
0.0168%
$7.00$39,892-21.08%
2024-02-01SaleChief Legal & Admin Officer
5,232
0.0154%
$6.99$36,559-21.08%
2023-12-28SaleChief Financial Officer
6,000
0.0181%
$12.08$72,480-51.71%
2023-12-21SaleChief Product Officer
7,370
0.0228%
$9.12$67,214-33.63%
2023-12-20SaleChief Product Officer
5,235
0.0169%
$9.10$47,639-30.50%
2023-12-19SaleChief Product Officer
7,395
0.0229%
$9.08$67,147-32.97%
2023-12-19SaleChief Financial Officer
5,580
0.0173%
$9.08$50,666-32.97%
2023-06-07SaleChief Product Officer
4,470
0.0149%
$10.03$44,834-26.91%
2023-05-23SaleChief Technology Officer
10,000
0.0313%
$10.02$100,200-30.74%
2023-05-23SalePresident and CEO
60,000
0.1896%
$10.12$607,200-30.74%
2023-02-16SalePresident and CEO
4,842
0.0153%
$10.12$49,001-27.20%
2023-02-15SalePresident and CEO
15,158
0.0477%
$10.29$155,976-28.38%

Insider Historical Profitability

<0.0001%
Knopp Kevin J.President and CEO
508981
1.4616%
$2.74523
Turner Michael S.Chief Legal & Admin Officer
9105
0.0261%
$2.7418<0.0001%
CRANDELL KEITH
5725045
16.4405%
$2.7410<0.0001%
ARCH Venture Fund VII, L.P.10 percent owner
5725045
16.4405%
$2.7410<0.0001%
Kedar Sharondirector
1077091
3.0931%
$2.7410<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
ARK Investment Management LLC$30.57M11.744.05M-6.85%-$2.25M0.11
Ameriprise Financial$14.26M5.481.89M-0.08%-$11,264.60<0.01
The Vanguard Group$13.22M5.081.75M+0.39%+$51,128.60<0.0001
Granahan Investment Management$13.09M5.031.73M-14.93%-$2.3M0.46
BlackRock$13.09M5.031.73M-3%-$404,883.87<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.